I-Mab receives Nasdaq notice over non-compliance with minimum bid price rule

I-Mab ( NASDAQ: IMAB ) received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market on March 19 indicating that the company is not in compliance with the $1 minimum bid price requirement under the Nasdaq Listing Rules. The company has ben provided with a period of 180 calendar days, or until September 15, 2025, to regain compliance with the listing rules. Source: Press Release More on I-Mab Biopharma I-Mab rises after update on early-stage trial for gastric cancer therapy I-Mab stock jumps 15% following pipeline update Seeking Alpha’s Quant Rating on I-Mab Biopharma.